Inmedix CEO Co-Chairs Immuno-autonomics Study Group at the 2019 Annual Meeting of the American College of Rheumatology
Andrew J. Holman, MD, Inmedix CEO & Co-founder, to highlight how linkage between the brain and immune function adversely affects autoimmune disease treatment. NORMANDY PARK, WA, USA, October 7, 2019 /EINPresswire.com/ -- Inmedix, the leader in next- …